[8-K] Inspire Medical Systems, Inc. Reports Material Event
Inspire Medical Systems (INSP) announced that Chief Financial Officer Richard J. Buchholz has notified the company he will step down to pursue other professional opportunities. Mr. Buchholz and the company entered a Transition and Separation Agreement under which his resignation will be effective on the earlier of December 31, 2025 or the date a permanent successor CFO commences employment. He will remain principal financial and accounting officer through that date and then serve as a financial advisor through February 28, 2026 while receiving base salary and benefits.
The agreement provides for a cash payment equal to nine months of his 2025 annual base salary and up to nine months of COBRA coverage. The company has engaged a leading executive search firm to recruit a new CFO. The filing discloses customary confidentiality, non-disparagement and release provisions and incorporates the full separation agreement as Exhibit 10.1 and a press release as Exhibit 99.1.
Inspire Medical Systems (INSP) ha annunciato che il Chief Financial Officer Richard J. Buchholz ha informato la societ脿 della sua intenzione di dimettersi per intraprendere altre opportunit脿 professionali. Il signor Buchholz e la societ脿 hanno sottoscritto un Accordo di Transizione e Separazione in base al quale le sue dimissioni avranno effetto alla data precedente tra il 31 dicembre 2025 o il giorno in cui un CFO successore permanente assumer脿 l鈥檌ncarico. Rimarr脿 responsabile principale delle funzioni finanziarie e contabili fino a tale data e poi prester脿 servizio come consulente finanziario fino al 28 febbraio 2026, continuando a ricevere stipendio base e benefit.
L鈥檃ccordo prevede un pagamento in contanti pari a nove mesi dell鈥檕ttenuto stipendio base annuo 2025 e fino a nove mesi di copertura COBRA. La societ脿 ha incaricato una primaria societ脿 di ricerca di dirigenti per reclutare un nuovo CFO. La comunicazione dichiara le consuete clausole di riservatezza, non denigrazione e liberatoria e incorpora il testo integrale dell鈥檃ccordo di separazione come Allegato 10.1 e un comunicato stampa come Allegato 99.1.
Inspire Medical Systems (INSP) anunci贸 que el director financiero Richard J. Buchholz notific贸 a la compa帽铆a que renunciar谩 para seguir otras oportunidades profesionales. El se帽or Buchholz y la compa帽铆a suscribieron un Acuerdo de Transici贸n y Separaci贸n seg煤n el cual su dimisi贸n ser谩 efectiva en la fecha que ocurra primero: el 31 de diciembre de 2025 o el d铆a en que un CFO sucesor permanente comience a trabajar. Permanecer谩 como principal responsable financiero y contable hasta esa fecha y luego actuar谩 como asesor financiero hasta el 28 de febrero de 2026, recibiendo salario base y beneficios.
El acuerdo contempla un pago en efectivo equivalente a nueve meses de su salario base anual de 2025 y hasta nueve meses de cobertura COBRA. La compa帽铆a ha contratado una firma l铆der de b煤squeda de ejecutivos para reclutar a un nuevo CFO. la presentaci贸n revela las habituales cl谩usulas de confidencialidad, no denigraci贸n y liberaci贸n, e incorpora el acuerdo de separaci贸n completo como Anexo 10.1 y un comunicado de prensa como Anexo 99.1.
Inspire Medical Systems(INSP)電� 斓滉碃鞛毂呾瀯鞛�(CFO) 毽矘霌� J. 攵�頋橅檧旄�(Richard J. Buchholz)臧� 雼るジ 歆侅梾鞝� 旮绊殞毳� 於旉惮頃橁赴 鞙勴暣 靷瀯頃� 瓴冹澊霛缄碃 須岇偓鞐� 韱惦炒頄堧嫟瓿� 氚滍憸頄堨姷雼堧嫟. 攵�頋橅檧旄� 鞌檧 須岇偓電� 鞝勴櫂 氚� 攵勲Μ 瓿勳暯(Transition and Separation Agreement)鞚� 觳搓舶頄堨溂氅�, 攴胳潣 靷瀯鞚� 2025雲� 12鞗� 31鞚� 霕愲姅 鞓侁惮 頉勳瀯 CFO臧� 旆瀯頃橂姅 雮� 欷� 毹检爛 霃勲灅頃橂姅 雮犾鞐� 氚滍毃霅╇媹雼�. 攴鸽姅 攴� 雮犾旯岇 欤检殧 鞛 氚� 須岅硠 雼措嫻 鞛勳洂鞙茧 雮晞鞛堦碃, 鞚错泟 2026雲� 2鞗� 28鞚缄箤歆� 鞛 瓿犽鞙茧靹� 攴茧頃橂┌ 旮半掣旮夑臣 氤惦Μ頉勳儩鞚� 歆�旮夒皼鞀惦媹雼�.
頃措嫻 瓿勳暯鞚� 2025雲� 鞐瓣皠 旮半掣旮夓潣 9臧滌洈攵勳棎 頃措嫻頃橂姅 順勱笀 歆�旮夑臣 斓滊寑 9臧滌洈鞚� COBRA 氤错棙 鞝侅毄鞚� 韽暔頃╇媹雼�. 須岇偓電� 鞁犼窚 CFO 毂勳毄鞚� 鞙勴暣 靹犽弰鞝侅澑 鞛勳洂 靹滌箻韼岇潉 靹犾瀯頄堨姷雼堧嫟. 鞝滌稖鞛愲鞐愲姅 韱奠儊鞝侅澑 牍勲皜鞙犾, 牍勲箘氚� 氚� 氅挫眳 臁绊暛鞚� 瓿店皽霅橃柎 鞛堨溂氅�, 鞝勳泊 攵勲Μ 瓿勳暯靹滊姅 觳秬氍胳劀 10.1搿�, 氤措弰鞛愲電� 觳秬氍胳劀 99.1搿� 韱淀暕霅橃柎 鞛堨姷雼堧嫟.
Inspire Medical Systems (INSP) a annonc茅 que le directeur financier Richard J. Buchholz a inform茅 la soci茅t茅 de son intention de d茅missionner pour poursuivre d鈥檃utres opportunit茅s professionnelles. M. Buchholz et la soci茅t茅 ont conclu un accord de transition et de s茅paration selon lequel sa d茅mission prendra effet 脿 la premi猫re des deux dates suivantes : le 31 d茅cembre 2025 ou la date d鈥檈ntr茅e en fonction d鈥檜n directeur financier successeur permanent. Il restera responsable principal des fonctions financi猫res et comptables jusqu鈥櫭� cette date, puis exercera en tant que conseiller financier jusqu鈥檃u 28 f茅vrier 2026, tout en percevant son salaire de base et ses avantages.
L鈥檃ccord pr茅voit un paiement en num茅raire 茅quivalant 脿 neuf mois de son salaire de base annuel 2025 et jusqu鈥櫭� neuf mois de couverture COBRA. La soci茅t茅 a mandat茅 un cabinet de recherche de cadres de premier plan pour recruter un nouveau CFO. Le d茅p么t divulgue les clauses habituelles de confidentialit茅, de non-d茅nigrement et de mainlev茅e, et incorpore l鈥檃ccord de s茅paration complet en tant qu鈥橝nnexe 10.1 ainsi qu鈥檜n communiqu茅 de presse en tant qu鈥橝nnexe 99.1.
Inspire Medical Systems (INSP) gab bekannt, dass Finanzvorstand Richard J. Buchholz das Unternehmen dar眉ber informiert hat, dass er zur眉cktreten werde, um anderen beruflichen M枚glichkeiten nachzugehen. Herr Buchholz und das Unternehmen haben eine 脺bergangs- und Trennungsvereinbarung (Transition and Separation Agreement) geschlossen, wonach sein R眉cktritt am fr眉heren der beiden Termine wirksam wird: dem 31. Dezember 2025 oder dem Zeitpunkt, an dem ein dauerhafter Nachfolger als CFO die T盲tigkeit aufnimmt. Bis dahin bleibt er leitender Finanz- und Rechnungswesen-Verantwortlicher und wird anschlie脽end bis zum 28. Februar 2026 als Finanzberater t盲tig sein, wobei er Grundgehalt und Leistungen erh盲lt.
Die Vereinbarung sieht eine Barauszahlung in H枚he von neun Monaten seines Jahresgrundgehalts 2025 sowie bis zu neun Monate COBRA-Versicherungsdeckung vor. Das Unternehmen hat eine f眉hrende Executive-Search-Firma mit der Suche nach einem neuen CFO beauftragt. Die Einreichung nennt 眉bliche Vertraulichkeits-, Nichtverunglimpfungs- und Freigabeklauseln und f眉gt die vollst盲ndige Trennungsvereinbarung als Anlage 10.1 und eine Pressemitteilung als Anlage 99.1 bei.
- Orderly transition with the CFO remaining in role until a successor is hired or December 31, 2025 and serving as an advisor through February 28, 2026
- No dispute reported 鈥� departure not due to disagreement over accounting practices or financial reporting
- Company engaged a leading executive search firm to recruit a new CFO, indicating a proactive replacement process
- Transparent disclosure of severance, benefits, and customary confidentiality and release provisions
- Departure of the CFO is a material senior leadership change that creates near-term uncertainty
- Cash obligation for nine months' base salary and COBRA coverage represents a one-time cash cost (amount not specified)
Insights
TL;DR: A planned CFO transition with a defined handover and severance reduces immediate governance risk but creates near-term leadership uncertainty.
The filing describes an orderly, contractually defined departure: the CFO will remain in role until a successor is hired or December 31, 2025 and then continue as an advisor through February 28, 2026. That structure supports continuity of financial oversight and reduces execution risk during reporting periods. The cash severance equal to nine months' base salary and COBRA coverage are within typical market practice for senior finance executives and are disclosed transparently. The company鈥檚 engagement of a leading executive search firm signals a proactive search, although time-to-hire and the profile of the successor will determine longer-term financial leadership quality. No disputes or accounting concerns were reported, which mitigates governance red flags.
TL;DR: Departure of the CFO is a material personnel change but the transition terms aim to preserve financial reporting stability.
From a financial operations perspective, maintaining the outgoing CFO as principal financial and accounting officer until a successor is onboarded and as an advisor thereafter supports uninterrupted internal controls and SEC reporting processes. The severance payment (nine months of 2025 base salary) represents a one-time cash cost; the filing does not quantify the dollar amount so the absolute financial impact cannot be assessed from the disclosure alone. The absence of disagreement over accounting or reporting is a comforting detail for investors monitoring potential restatements or control issues. Overall, the disclosure is routine for executive transitions and contains provisions designed to minimize disruption.
Inspire Medical Systems (INSP) ha annunciato che il Chief Financial Officer Richard J. Buchholz ha informato la societ脿 della sua intenzione di dimettersi per intraprendere altre opportunit脿 professionali. Il signor Buchholz e la societ脿 hanno sottoscritto un Accordo di Transizione e Separazione in base al quale le sue dimissioni avranno effetto alla data precedente tra il 31 dicembre 2025 o il giorno in cui un CFO successore permanente assumer脿 l鈥檌ncarico. Rimarr脿 responsabile principale delle funzioni finanziarie e contabili fino a tale data e poi prester脿 servizio come consulente finanziario fino al 28 febbraio 2026, continuando a ricevere stipendio base e benefit.
L鈥檃ccordo prevede un pagamento in contanti pari a nove mesi dell鈥檕ttenuto stipendio base annuo 2025 e fino a nove mesi di copertura COBRA. La societ脿 ha incaricato una primaria societ脿 di ricerca di dirigenti per reclutare un nuovo CFO. La comunicazione dichiara le consuete clausole di riservatezza, non denigrazione e liberatoria e incorpora il testo integrale dell鈥檃ccordo di separazione come Allegato 10.1 e un comunicato stampa come Allegato 99.1.
Inspire Medical Systems (INSP) anunci贸 que el director financiero Richard J. Buchholz notific贸 a la compa帽铆a que renunciar谩 para seguir otras oportunidades profesionales. El se帽or Buchholz y la compa帽铆a suscribieron un Acuerdo de Transici贸n y Separaci贸n seg煤n el cual su dimisi贸n ser谩 efectiva en la fecha que ocurra primero: el 31 de diciembre de 2025 o el d铆a en que un CFO sucesor permanente comience a trabajar. Permanecer谩 como principal responsable financiero y contable hasta esa fecha y luego actuar谩 como asesor financiero hasta el 28 de febrero de 2026, recibiendo salario base y beneficios.
El acuerdo contempla un pago en efectivo equivalente a nueve meses de su salario base anual de 2025 y hasta nueve meses de cobertura COBRA. La compa帽铆a ha contratado una firma l铆der de b煤squeda de ejecutivos para reclutar a un nuevo CFO. la presentaci贸n revela las habituales cl谩usulas de confidencialidad, no denigraci贸n y liberaci贸n, e incorpora el acuerdo de separaci贸n completo como Anexo 10.1 y un comunicado de prensa como Anexo 99.1.
Inspire Medical Systems(INSP)電� 斓滉碃鞛毂呾瀯鞛�(CFO) 毽矘霌� J. 攵�頋橅檧旄�(Richard J. Buchholz)臧� 雼るジ 歆侅梾鞝� 旮绊殞毳� 於旉惮頃橁赴 鞙勴暣 靷瀯頃� 瓴冹澊霛缄碃 須岇偓鞐� 韱惦炒頄堧嫟瓿� 氚滍憸頄堨姷雼堧嫟. 攵�頋橅檧旄� 鞌檧 須岇偓電� 鞝勴櫂 氚� 攵勲Μ 瓿勳暯(Transition and Separation Agreement)鞚� 觳搓舶頄堨溂氅�, 攴胳潣 靷瀯鞚� 2025雲� 12鞗� 31鞚� 霕愲姅 鞓侁惮 頉勳瀯 CFO臧� 旆瀯頃橂姅 雮� 欷� 毹检爛 霃勲灅頃橂姅 雮犾鞐� 氚滍毃霅╇媹雼�. 攴鸽姅 攴� 雮犾旯岇 欤检殧 鞛 氚� 須岅硠 雼措嫻 鞛勳洂鞙茧 雮晞鞛堦碃, 鞚错泟 2026雲� 2鞗� 28鞚缄箤歆� 鞛 瓿犽鞙茧靹� 攴茧頃橂┌ 旮半掣旮夑臣 氤惦Μ頉勳儩鞚� 歆�旮夒皼鞀惦媹雼�.
頃措嫻 瓿勳暯鞚� 2025雲� 鞐瓣皠 旮半掣旮夓潣 9臧滌洈攵勳棎 頃措嫻頃橂姅 順勱笀 歆�旮夑臣 斓滊寑 9臧滌洈鞚� COBRA 氤错棙 鞝侅毄鞚� 韽暔頃╇媹雼�. 須岇偓電� 鞁犼窚 CFO 毂勳毄鞚� 鞙勴暣 靹犽弰鞝侅澑 鞛勳洂 靹滌箻韼岇潉 靹犾瀯頄堨姷雼堧嫟. 鞝滌稖鞛愲鞐愲姅 韱奠儊鞝侅澑 牍勲皜鞙犾, 牍勲箘氚� 氚� 氅挫眳 臁绊暛鞚� 瓿店皽霅橃柎 鞛堨溂氅�, 鞝勳泊 攵勲Μ 瓿勳暯靹滊姅 觳秬氍胳劀 10.1搿�, 氤措弰鞛愲電� 觳秬氍胳劀 99.1搿� 韱淀暕霅橃柎 鞛堨姷雼堧嫟.
Inspire Medical Systems (INSP) a annonc茅 que le directeur financier Richard J. Buchholz a inform茅 la soci茅t茅 de son intention de d茅missionner pour poursuivre d鈥檃utres opportunit茅s professionnelles. M. Buchholz et la soci茅t茅 ont conclu un accord de transition et de s茅paration selon lequel sa d茅mission prendra effet 脿 la premi猫re des deux dates suivantes : le 31 d茅cembre 2025 ou la date d鈥檈ntr茅e en fonction d鈥檜n directeur financier successeur permanent. Il restera responsable principal des fonctions financi猫res et comptables jusqu鈥櫭� cette date, puis exercera en tant que conseiller financier jusqu鈥檃u 28 f茅vrier 2026, tout en percevant son salaire de base et ses avantages.
L鈥檃ccord pr茅voit un paiement en num茅raire 茅quivalant 脿 neuf mois de son salaire de base annuel 2025 et jusqu鈥櫭� neuf mois de couverture COBRA. La soci茅t茅 a mandat茅 un cabinet de recherche de cadres de premier plan pour recruter un nouveau CFO. Le d茅p么t divulgue les clauses habituelles de confidentialit茅, de non-d茅nigrement et de mainlev茅e, et incorpore l鈥檃ccord de s茅paration complet en tant qu鈥橝nnexe 10.1 ainsi qu鈥檜n communiqu茅 de presse en tant qu鈥橝nnexe 99.1.
Inspire Medical Systems (INSP) gab bekannt, dass Finanzvorstand Richard J. Buchholz das Unternehmen dar眉ber informiert hat, dass er zur眉cktreten werde, um anderen beruflichen M枚glichkeiten nachzugehen. Herr Buchholz und das Unternehmen haben eine 脺bergangs- und Trennungsvereinbarung (Transition and Separation Agreement) geschlossen, wonach sein R眉cktritt am fr眉heren der beiden Termine wirksam wird: dem 31. Dezember 2025 oder dem Zeitpunkt, an dem ein dauerhafter Nachfolger als CFO die T盲tigkeit aufnimmt. Bis dahin bleibt er leitender Finanz- und Rechnungswesen-Verantwortlicher und wird anschlie脽end bis zum 28. Februar 2026 als Finanzberater t盲tig sein, wobei er Grundgehalt und Leistungen erh盲lt.
Die Vereinbarung sieht eine Barauszahlung in H枚he von neun Monaten seines Jahresgrundgehalts 2025 sowie bis zu neun Monate COBRA-Versicherungsdeckung vor. Das Unternehmen hat eine f眉hrende Executive-Search-Firma mit der Suche nach einem neuen CFO beauftragt. Die Einreichung nennt 眉bliche Vertraulichkeits-, Nichtverunglimpfungs- und Freigabeklauseln und f眉gt die vollst盲ndige Trennungsvereinbarung als Anlage 10.1 und eine Pressemitteilung als Anlage 99.1 bei.
FAQ
What did Inspire Medical Systems (INSP) disclose about its CFO change?
When will the CFO resignation become effective at INSP?
Will the outgoing CFO remain involved after resigning?
What severance or payments will the departing CFO receive?
Did the company report any disagreement related to accounting or financial reporting?
